BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36398696)

  • 1. SOCS2 regulation of growth hormone signaling requires a canonical interaction with phosphotyrosine.
    Li K; Meza Guzman LG; Whitehead L; Leong E; Kueh A; Alexander WS; Kershaw NJ; Babon JJ; Doggett K; Nicholson SE
    Biosci Rep; 2022 Dec; 42(12):. PubMed ID: 36398696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOCS2 is the critical regulator of GH action in murine growth plate chondrogenesis.
    Pass C; MacRae VE; Huesa C; Faisal Ahmed S; Farquharson C
    J Bone Miner Res; 2012 May; 27(5):1055-66. PubMed ID: 22228213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels.
    Vesterlund M; Zadjali F; Persson T; Nielsen ML; Kessler BM; Norstedt G; Flores-Morales A
    PLoS One; 2011; 6(9):e25358. PubMed ID: 21980433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOCS2 negatively regulates growth hormone action in vitro and in vivo.
    Greenhalgh CJ; Rico-Bautista E; Lorentzon M; Thaus AL; Morgan PO; Willson TA; Zervoudakis P; Metcalf D; Street I; Nicola NA; Nash AD; Fabri LJ; Norstedt G; Ohlsson C; Flores-Morales A; Alexander WS; Hilton DJ
    J Clin Invest; 2005 Feb; 115(2):397-406. PubMed ID: 15690087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct stimulation of bone mass by increased GH signalling in the osteoblasts of Socs2-/- mice.
    Dobie R; MacRae VE; Huesa C; van't Hof R; Ahmed SF; Farquharson C
    J Endocrinol; 2014 Oct; 223(1):93-106. PubMed ID: 25074853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOCS2 induces neurite outgrowth by regulation of epidermal growth factor receptor activation.
    Goldshmit Y; Walters CE; Scott HJ; Greenhalgh CJ; Turnley AM
    J Biol Chem; 2004 Apr; 279(16):16349-55. PubMed ID: 14764607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of an exosite on the SOCS2-SH2 domain that enhances SH2 binding to phosphorylated ligands.
    Linossi EM; Li K; Veggiani G; Tan C; Dehkhoda F; Hockings C; Calleja DJ; Keating N; Feltham R; Brooks AJ; Li SS; Sidhu SS; Babon JJ; Kershaw NJ; Nicholson SE
    Nat Commun; 2021 Dec; 12(1):7032. PubMed ID: 34857742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of suppressor of cytokine signaling 2 (SOCS2) on fat metabolism induced by growth hormone (GH) in porcine primary adipocyte.
    Yang HL; Sun C; Sun C; Qi RL
    Mol Biol Rep; 2012 Sep; 39(9):9113-22. PubMed ID: 22729878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased linear bone growth by GH in the absence of SOCS2 is independent of IGF-1.
    Dobie R; Ahmed SF; Staines KA; Pass C; Jasim S; MacRae VE; Farquharson C
    J Cell Physiol; 2015 Nov; 230(11):2796-806. PubMed ID: 25833299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOCS2 Silencing Improves Somatic Growth without Worsening Kidney Function in CKD.
    Landau D; Assadi MH; Abu Hilal R; Chen Y; Rabkin R; Segev Y
    Am J Nephrol; 2020; 51(7):520-526. PubMed ID: 32541140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer.
    Iglesias-Gato D; Chuan YC; Wikström P; Augsten S; Jiang N; Niu Y; Seipel A; Danneman D; Vermeij M; Fernandez-Perez L; Jenster G; Egevad L; Norstedt G; Flores-Morales A
    Carcinogenesis; 2014 Jan; 35(1):24-33. PubMed ID: 24031028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 17β-Estradiol positively modulates growth hormone signaling through the reduction of SOCS2 negative feedback in human osteoblasts.
    Bolamperti S; Mrak E; Moro G; Sirtori P; Fraschini G; Guidobono F; Rubinacci A; Villa I
    Bone; 2013 Jul; 55(1):84-92. PubMed ID: 23567159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor of cytokine signaling 2 (SOCS2) associates with FLT3 and negatively regulates downstream signaling.
    Kazi JU; Rönnstrand L
    Mol Oncol; 2013 Jun; 7(3):693-703. PubMed ID: 23548639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic mice.
    Michaylira CZ; Ramocki NM; Simmons JG; Tanner CK; McNaughton KK; Woosley JT; Greenhalgh CJ; Lund PK
    Endocrinology; 2006 Apr; 147(4):1632-41. PubMed ID: 16410303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects.
    Rico-Bautista E; Greenhalgh CJ; Tollet-Egnell P; Hilton DJ; Alexander WS; Norstedt G; Flores-Morales A
    Mol Endocrinol; 2005 Mar; 19(3):781-93. PubMed ID: 15563548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knock your SOCS off!
    Leroith D; Nissley P
    J Clin Invest; 2005 Feb; 115(2):233-6. PubMed ID: 15690080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Point Mutation in Suppressor of Cytokine Signalling 2 (Socs2) Increases the Susceptibility to Inflammation of the Mammary Gland while Associated with Higher Body Weight and Size and Higher Milk Production in a Sheep Model.
    Rupp R; Senin P; Sarry J; Allain C; Tasca C; Ligat L; Portes D; Woloszyn F; Bouchez O; Tabouret G; Lebastard M; Caubet C; Foucras G; Tosser-Klopp G
    PLoS Genet; 2015 Dec; 11(12):e1005629. PubMed ID: 26658352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor of cytokine signaling 2 (
    Dobie R; MacRae VE; Pass C; Milne EM; Ahmed SF; Farquharson C
    Dis Model Mech; 2018 Jan; 11(1):. PubMed ID: 29343614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo.
    Michaylira CZ; Simmons JG; Ramocki NM; Scull BP; McNaughton KK; Fuller CR; Lund PK
    Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G472-81. PubMed ID: 16574995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational and functional analysis of growth hormone (GH)-regulated genes identifies the transcriptional repressor B-cell lymphoma 6 (Bc16) as a participant in GH-regulated transcription.
    Chen Y; Lin G; Huo JS; Barney D; Wang Z; Livshiz T; States DJ; Qin ZS; Schwartz J
    Endocrinology; 2009 Aug; 150(8):3645-54. PubMed ID: 19406940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.